Associated Papers
Clinical integration of germline findings from a tumor testing precision medicine program.
Sanabria-Salas MC et al.
Bmc Cancer, 2025
39885482 (PubMed )
Supplement: 12885_2025_13487_MOESM1_ESM.pdf
Advancing Precision Oncology in Hereditary Paraganglioma-Pheochromocytoma Syndromes: Integrated Interpretation and Data Sharing of the Germline and Tumor Genomes.
Rana HQ et al.
Cancers, 2024
38473309 (PubMed )
Supplement: cancers-16-00947-s001.zip › Supplementary_Table_S2_-_INT2GRATE___HPPGL_Variant_Data_for_Patients__in_Cohort_2_.xlsx › Sheet1
Succinate dehydrogenase variants in paraganglioma: why are B subunit variants 'bad'?
Gruber LM et al.
Endocrine Oncology (bristol, England), 2023
37434649 (PubMed )
Supplement: supplementary_table_1.xlsx › Missense_Variants
Investigation of germline variants in Bahraini women with breast cancer using next-generation sequencing based-multigene panel.
Al-Kafaji G et al.
Plos One, 2023
Novel germline mutations in the SDHB and SDHD genes in Japanese pheochromocytomas.
Isobe K et al.
Hormone Research, 2007
SDH mutations in patients affected by paraganglioma syndromes: a personal experience.
Mannelli M et al.
Annals of the New York Academy of Sciences, 2006
Phenotype variability of neural crest derived tumours in six Italian families segregating the same founder SDHD mutation Q109X.
Simi L et al.
Journal of Medical Genetics, 2005
Select a paper to view details